Biotechnology - , , Spain
IkerChem is a leader in the design and development of novel oncology drugs in the epigenetics arena. The company has a strong pipeline of products in development in the principal target areas of DNA Methyltransferase (DNMT) inhibitors with a novel mode of action, next generation potent Histone Deacetylase 6 (HDAC6) inhibitors and the GASC1 target within the JMJ Histone demethylase family.